World-first cancer screening technology trialled in Singapore Singapore, November 2020 – Two of Singapore’s leading hospitals and medical research centres, National University Hospital (NUH) and Singapore General Hospital (SGH), are trialling a new diagnostic test...
X-ZELL secures investment by German industrial services powerhouse, DIAG Singapore/ Essen, October 2019 – German industrial services specialist, Deutsche Industrieanlagen (DIAG), has officially joined X-ZELL’s US$3m Seed+ funding round. Ranked amongst Asia’s 50 most...
X-ZELL ranked among Top 50 health tech start-ups in Asia Singapore, October 2019 – X-ZELL has been ranked amongst the 50 leading health tech start-ups in Asia for the second year running. Every year, the prestigious list is compiled by Singapore-based analytics and...
X-ZELL global HQ now open for business in Singapore Singapore, May 2019 – X-ZELL, only recently named one of Asia’s 20 most innovative health tech start-ups, today opened its new global headquarters at Paya Lebar Square in Singapore, conveniently located between...
X-ZELL Cryoimmunostaining™ World Premiere Singapore, February 2019 – Rare cell detection specialist X-ZELL is proud to announce the world premiere of the world’s first 8-channel multiplexing technology, Cryoimmunostaining™ . Originally designed to enable the company’s...
